Importance of minimal residual disease testing during the second year of therapy for children with acute lymphoblastic leukemia. (Q53940865)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Importance of minimal residual disease testing during the second year of therapy for children with acute lymphoblastic leukemia. |
scientific article |
Statements
Importance of minimal residual disease testing during the second year of therapy for children with acute lymphoblastic leukemia (English)
Chengyuan Xue
Luciano Dalla Pozza
Glenn M Marshall
Edward Kwan
Ling Zhu
Daniella Ferrara
Alexander Morley
Boyd Webster
Keith Waters
1 February 2003